IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 3 filers reported holding IMMUNOGEN INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | +412.5% | 38,733 | +23.9% | 0.01% | +500.0% |
| Q1 2023 | $120 | -100.0% | 31,268 | -91.3% | 0.00% | -95.7% |
| Q3 2022 | $1,724,000 | +153.2% | 360,717 | +138.2% | 0.02% | +187.5% |
| Q2 2022 | $681,000 | -5.0% | 151,436 | +0.5% | 0.01% | -11.1% |
| Q1 2022 | $717,000 | +128.3% | 150,705 | +256.5% | 0.01% | +200.0% |
| Q4 2021 | $314,000 | -81.3% | 42,277 | -85.7% | 0.00% | -87.0% |
| Q3 2021 | $1,678,000 | +118.5% | 296,002 | +154.2% | 0.02% | +187.5% |
| Q2 2021 | $768,000 | -1.4% | 116,466 | +21.1% | 0.01% | -27.3% |
| Q1 2021 | $779,000 | +499.2% | 96,140 | +375.9% | 0.01% | +1000.0% |
| Q4 2020 | $130,000 | -54.2% | 20,200 | -74.4% | 0.00% | -83.3% |
| Q3 2020 | $284,000 | +491.7% | 79,013 | +662.2% | 0.01% | +500.0% |
| Q2 2020 | $48,000 | -67.8% | 10,367 | -76.2% | 0.00% | -87.5% |
| Q1 2020 | $149,000 | – | 43,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |